About: covid:PMC7295852

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7295852 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Curigliano, Giuseppe Trapani, Dario Cardoso, Fatima Cortes, Javier Criscitiello, Carmen Delaloge, Suzette Gnant, Michael Loibl, Sibylle Paluch-Shimon, Shani Poortman, Philip Senkus, Elzbieta Di Cosimo, Serena de Azambuja, Evandro
is schema:about of	named entity 'era' named entity 'COVID-19' named entity 'clinical trials' named entity 'health services' named entity 'breast cancer' named entity 'treatment compliance' named entity 'irradiation' named entity 'chemotherapeutics' named entity 'oncology' named entity 'COVID-19' named entity 'clinical trials' named entity 'metastatic breast cancer' named entity 'oncologists' named entity 'COVID-19' named entity 'radiation therapy' named entity 'breast cancer' named entity 'home-based care' named entity 'public health' named entity 'neoadjuvant therapy' named entity 'preclinical' named entity 'WHO' named entity 'non-maleficence' named entity 'clinical guidelines' named entity 'Aromatase inhibitors' named entity 'MCBS' named entity 'neoplasia' named entity 'COVID-19' named entity 'WHO' named entity 'telemedicine' named entity 'neoadjuvant chemotherapy' named entity 'infection' named entity 'chemotherapy' named entity 'elderly patients' named entity 'prognostic significance' named entity 'evidence-based' named entity 'health systems' named entity 'breast masses' named entity 'breast cancer' named entity 'HER2' named entity 'HER2' named entity 'Europe' named entity 'cancer biology' named entity 'neoadjuvant' named entity 'infection' named entity 'breast cancer' named entity 'outpatient visits' named entity 'growth factors' named entity '1.10' named entity 'MCBS' named entity 'high-risk' named entity 'healthcare professionals' named entity 'cancer care' named entity 'telemedicine' named entity 'surgical excision' named entity 'medical oncology' named entity 'public health' named entity 'chemotherapy' named entity 'early start' named entity 'infection' named entity 'asymptomatic' named entity 'prognosis' named entity 'medical community' named entity 'dissertation' named entity 'antineoplastic' named entity 'covid-19' named entity 'brain metastases' named entity 'hormone' named entity 'cancer care' named entity 'oncology' named entity 'prognostic' named entity 'anamnestic' named entity 'high-risk' named entity 'telemedicine' named entity 'denosumab' named entity 'metastatic' named entity 'COVID-19' named entity 'chemotherapy regimens' named entity 'oncology' named entity 'tumour' named entity 'comorbidities' named entity 'health services' named entity 'clinical presentation' named entity 'breast surgery' named entity 'COVID-19' named entity 'oncology' named entity 'toxicity' named entity 'decision making'

Attributes

Values

Creator

Curigliano, Giuseppe
Trapani, Dario
Cardoso, Fatima
Cortes, Javier
Criscitiello, Carmen
Delaloge, Suzette
Gnant, Michael
Loibl, Sibylle
Paluch-Shimon, Shani
Poortman, Philip
Senkus, Elzbieta
Di Cosimo, Serena
de Azambuja, Evandro

is schema:about of

named entity 'era'
named entity 'COVID-19'
named entity 'clinical trials'
named entity 'health services'
named entity 'breast cancer'
named entity 'treatment compliance'
named entity 'irradiation'
named entity 'chemotherapeutics'
named entity 'oncology'
named entity 'COVID-19'
named entity 'clinical trials'
named entity 'metastatic breast cancer'
named entity 'oncologists'
named entity 'COVID-19'
named entity 'radiation therapy'
named entity 'breast cancer'
named entity 'home-based care'
named entity 'public health'
named entity 'neoadjuvant therapy'
named entity 'preclinical'
named entity 'WHO'
named entity 'non-maleficence'
named entity 'clinical guidelines'
named entity 'Aromatase inhibitors'
named entity 'MCBS'
named entity 'neoplasia'
named entity 'COVID-19'
named entity 'WHO'
named entity 'telemedicine'
named entity 'neoadjuvant chemotherapy'
named entity 'infection'
named entity 'chemotherapy'
named entity 'elderly patients'
named entity 'prognostic significance'
named entity 'evidence-based'
named entity 'health systems'
named entity 'breast masses'
named entity 'breast cancer'
named entity 'HER2'
named entity 'HER2'
named entity 'Europe'
named entity 'cancer biology'
named entity 'neoadjuvant'
named entity 'infection'
named entity 'breast cancer'
named entity 'outpatient visits'
named entity 'growth factors'
named entity '1.10'
named entity 'MCBS'
named entity 'high-risk'
named entity 'healthcare professionals'
named entity 'cancer care'
named entity 'telemedicine'
named entity 'surgical excision'
named entity 'medical oncology'
named entity 'public health'
named entity 'chemotherapy'
named entity 'early start'
named entity 'infection'
named entity 'asymptomatic'
named entity 'prognosis'
named entity 'medical community'
named entity 'dissertation'
named entity 'antineoplastic'
named entity 'covid-19'
named entity 'brain metastases'
named entity 'hormone'
named entity 'cancer care'
named entity 'oncology'
named entity 'prognostic'
named entity 'anamnestic'
named entity 'high-risk'
named entity 'telemedicine'
named entity 'denosumab'
named entity 'metastatic'
named entity 'COVID-19'
named entity 'chemotherapy regimens'
named entity 'oncology'
named entity 'tumour'
named entity 'comorbidities'
named entity 'health services'
named entity 'clinical presentation'
named entity 'breast surgery'
named entity 'COVID-19'
named entity 'oncology'
named entity 'toxicity'
named entity 'decision making'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software